Incorporating the possibility of cure into network meta-analyses: A case study from resected Stage III/IV melanoma
Research Synthesis Methods · 2026-01 · 17 (1) · 157-169
DOI: 10.1017/rsm.2025.10038 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Research Synthesis Methods, online erschienen am 15.10.2025. Verfasst von Keith Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Precision AQ, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol Myers Squibb Foundation.
Abstract (Originalsprache)
In many areas of oncology, cancer drugs are now associated with long-term survivorship and mixture cure models (MCM) are increasingly being used for survival analysis. The objective of this article was to propose a methodology for conducting network meta-analysis (NMA) of MCM. This method was illustrated through a case study evaluating recurrence-free survival (RFS) with adjuvant therapy for stage III/IV resected melanoma. For the case study, the MCM NMA was conducted by: (1) fitting MCMs to each trial included within the network of evidence; and (2) incorporating the parameters of the MCMs into a multivariate NMA. Outputs included relative effect estimates for the MCM NMA as well as absolute estimates of survival (RFS), modeled within the Bayesian multivariate NMA, by incorporating absolute baseline effects of the reference treatment. The case study was intended for illustrative purposes of the MCM NMA methodology and is not meant for clinical interpretation. The case study demonstrated the feasibility of conducting an MCM NMA and highlighted key issues and considerations when conducting such analyses, including plausibility of cure, maturity of data, process for model selection, and the presentation and interpretation of results. MCM NMA provides a method of comparative survival that acknowledges the benefit newer treatments may confer on a subset of patients, resulting in long-term survival and reflection of this survival in extrapolation. In the future, this method may provide an additional metric to compare treatments that is of value to patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Precision AQ, Vancouver, BC, Canada.
- Bristol Myers Squibb, Princeton, NJ, USA.
- School of Pharmacy, https://ror.org/043mz5j54University of California San Francisco, San Francisco, CA, USA.
Förderung
- Bristol Myers Squibb Foundation
Zitieren
APA
Chan, K., Goring, S., Toor, K., Kurt, M., Moshyk, A., & Jansen, J. (2026). Incorporating the possibility of cure into network meta-analyses: A case study from resected Stage III/IV melanoma. Research Synthesis Methods, 17(1), 157-169. https://doi.org/10.1017/rsm.2025.10038
Vancouver
Chan K, Goring S, Toor K, Kurt M, Moshyk A, Jansen J. Incorporating the possibility of cure into network meta-analyses: A case study from resected Stage III/IV melanoma. Research Synthesis Methods. 2026;17(1):157-169. doi:10.1017/rsm.2025.10038
BibTeX
@article{Chan2026,
author = {Chan, Keith and Goring, Sarah and Toor, Kabirraaj and Kurt, Murat and Moshyk, Andriy and Jansen, Jeroen},
title = {Incorporating the possibility of cure into network meta-analyses: A case study from resected Stage III/IV melanoma},
journal = {Research Synthesis Methods},
year = {2026},
volume = {17},
number = {1},
pages = {157--169},
doi = {10.1017/rsm.2025.10038}
}
EUVIMED